Literature DB >> 17003817

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

K Uhlig1, A Macleod, J Craig, J Lau, A S Levey, A Levin, L Moist, E Steinberg, R Walker, C Wanner, N Lameire, G Eknoyan.   

Abstract

Considerable variation in grading systems used to rate the strength of guideline recommendations and the quality of the supporting evidence in Nephrology highlights the need for a uniform, internationally accepted, rigorous system. In 2004, Kidney Disease: Improving Global Outcomes (KDIGO) commissioned a methods expert group to recommend an approach for grading in future nephrology guidelines. This position statement by KDIGO recommends adopting the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach for the grading of evidence and guidelines on interventions. The GRADE approach appraises systematic reviews of the benefits and harms of an intervention to determine its net health benefit. The system considers the design, quality, and quantity of studies as well as the consistency and directness of findings when grading the quality of evidence. The strength of the recommendation builds on the quality of the evidence and additional considerations including costs. Adaptations of the GRADE approach are presented to address some issues pertinent to the field of nephrology, including (1) the need to extrapolate from studies performed predominantly in patients without kidney disease, and (2) the need to use qualitative summaries of effects when it is not feasible to quantitatively summarize them. Further refinement of the system will be required for grading of evidence on questions other than those related to intervention effects, such as diagnostic accuracy and prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 17003817     DOI: 10.1038/sj.ki.5001875

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  48 in total

Review 1.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

Review 2.  Quality Measures for Dialysis: Time for a Balanced Scorecard.

Authors:  Alan S Kliger
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-27       Impact factor: 8.237

3.  Rate of change in renal function and mortality in elderly treated hypertensive patients.

Authors:  Enayet K Chowdhury; Robyn G Langham; Zanfina Ademi; Alice Owen; Henry Krum; Lindon M H Wing; Mark R Nelson; Christopher M Reid
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

Review 4.  [New KDIGO guidelines on acute kidney injury. Practical recommendations].

Authors:  A Zarbock; S John; A Jörres; D Kindgen-Milles
Journal:  Anaesthesist       Date:  2014-07       Impact factor: 1.041

5.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

6.  Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives.

Authors:  Jer-Ming Chang; Shang-Jyh Hwang; Yusuke Tsukamoto; Hung-Chun Chen
Journal:  Clin Exp Nephrol       Date:  2012-03-03       Impact factor: 2.801

7.  Guiding principles and checklist for population-based quality metrics.

Authors:  Mahesh Krishnan; Steven M Brunelli; Franklin W Maddux; Thomas F Parker; Douglas Johnson; Allen R Nissenson; Allan Collins; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

8.  Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.

Authors:  Kunitoshi Iseki; Masaru Horio; Enyu Imai; Seiichi Matsuo; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-10-15       Impact factor: 2.801

Review 9.  Building on evidence to improve patient care.

Authors:  Evelien Snauwaert; Johan VandeWalle; Evi V Nagler; Wim Van Biesen
Journal:  Pediatr Nephrol       Date:  2016-12-09       Impact factor: 3.714

Review 10.  Kidney disease: improving global outcomes.

Authors:  Kai-Uwe Eckardt; Bertram L Kasiske
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.